IUCPQ (Laval University)

Québec GLV 4G5

0 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Chronic Kidney Disease, Heart Failure, Idiopathic Pulmonary Fibrosis, Mesothelioma, Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema

Studies at this site

• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early
• Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) — Completed